ARTICLE | Company News
GlaxoSmithKline receptor deal with m-phasys
April 17, 2001 7:00 AM UTC
GlaxoSmithKline (GSK; LSE:GSK) and m-phasys (Tubingen, Germany) will determine in vitro the function of an undisclosed G-protein coupled receptor. m-phasys will use its M-Fold refolding technology, wh...